Literature DB >> 8981781

Developmental effects of fumonisin B1 in mice.

R V Reddy1, G Johnson, G E Rottinghaus, S W Casteel, C S Reddy.   

Abstract

Developmental and toxic effects of aqueous extracts of F. moniliforme culture material containing known levels of fumonisin B1 were recently reported in mice and included maternal hepatotoxicity and lethality, maternal body weight gain reduction, increased embryonic resorptions, reduced offspring body weights, and fetal malformations including cleft palate, hydrocephalus, malformed ribs and incomplete digital and sternal ossification. These studies also suggested that the effects of the fungal extract on the mouse offspring may be mediated via maternal effects. The contribution of fumonisin B1 (FB1), a major toxic metabolite of F. moniliforme, in the induction of these effects was evaluated in this study by administering 0 to 100 mg pure FB1/kg of body weight on gestational days (GD) 7 through 15 to pregnant Charles River CD1 mice and assessing maternal health and fetal development till the end of gestation. Doses of 25 mg/kg or higher of pure FB1 induced maternal liver lesions (mostly necrotic changes), associated with ascites and increased hepatocytic nuclear diameter. Fumonisin doses of 50 mg/kg or higher also resulted in significantly increased maternal ALT on GD12, and reduced offspring bodyweights on GD18. Increased resorptions and decreased numbers of live offspring were only evident at 100 mg FB1/kg body weight. Offspring exhibited dose-dependent increase in the incidence and severity of hydrocephalus of both the lateral and third ventricles at doses of 25 mg/kg or higher. Doses of 25 mg/kg or higher also increased the sphinganine/sphingosine (Sa/So) ratios in maternal but not fetal livers. These results suggest that FB1 may be a developmental toxicant accounting for most but not all earlier reported effects of F. moniliforme culture extract. Association of FB1 effects on the offspring with maternal hepatoxicity and with alteration of Sa/So ratio in maternal but not fetal liver supported the earlier claim that FB1 effects on the mouse offspring are mediated by maternal hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981781     DOI: 10.1007/bf00436724

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  18 in total

1.  Experimental reproduction of ELEM. A study to determine the minimum toxic dose in ponies.

Authors:  T M Wilson; P F Ross; D L Owens; L G Rice; S A Green; S J Jenkins; H A Nelson
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

2.  Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.

Authors:  H S Yoo; W P Norred; E Wang; A H Merrill; R T Riley
Journal:  Toxicol Appl Pharmacol       Date:  1992-05       Impact factor: 4.219

3.  Effects of temperature and incubation period on production of fumonisin B1 by Fusarium moniliforme.

Authors:  J F Alberts; W C Gelderblom; P G Thiel; W F Marasas; D J Van Schalkwyk; Y Behrend
Journal:  Appl Environ Microbiol       Date:  1990-06       Impact factor: 4.792

4.  Characterization of fumonisin toxicity in orally and intravenously dosed swine.

Authors:  W M Haschek; G Motelin; D K Ness; K S Harlin; W F Hall; R F Vesonder; R E Peterson; V R Beasley
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

5.  Hepato- and cardiotoxicity of Fusarium verticillioides (F. moniliforme) isolates from Southern African maize.

Authors:  N P Kriek; W F Marasas; P G Thiel
Journal:  Food Cosmet Toxicol       Date:  1981-08

6.  Developmental toxicity in hamsters of an aqueous extract of Fusarium moniliforme culture material containing known quantities of fumonisin B1.

Authors:  J L Floss; S W Casteel; G C Johnson; G E Rottinghaus; G F Krause
Journal:  Vet Hum Toxicol       Date:  1994-02

7.  Carcinogenicity of Fusarium moniliforme culture material in rats.

Authors:  K Jaskiewicz; S J van Rensburg; W F Marasas; W C Gelderblom
Journal:  J Natl Cancer Inst       Date:  1987-02       Impact factor: 13.506

8.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.

Authors:  E Wang; W P Norred; C W Bacon; R T Riley; A H Merrill
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

Review 9.  A review and update of animal toxicoses associated with fumonisin-contaminated feeds and production of fumonisins by Fusarium isolates.

Authors:  P F Ross; L G Rice; G D Osweiler; P E Nelson; J L Richard; T M Wilson
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

10.  Developmental effects of fumonisin B1-containing Fusarium moniliforme culture extract in CD1 mice.

Authors:  S M Gross; R V Reddy; G E Rottinghaus; G Johnson; C S Reddy
Journal:  Mycopathologia       Date:  1994-11       Impact factor: 2.574

View more
  8 in total

1.  Morphology and Chemical Coding of Rat Duodenal Enteric Neurons following Prenatal Exposure to Fumonisins.

Authors:  Katarzyna Kras; Halyna Rudyk; Siemowit Muszyński; Ewa Tomaszewska; Piotr Dobrowolski; Volodymyr Kushnir; Viktor Muzyka; Oksana Brezvyn; Marcin B Arciszewski; Ihor Kotsyumbas
Journal:  Animals (Basel)       Date:  2022-04-19       Impact factor: 3.231

2.  Fumonisins: current research trends in developmental toxicology.

Authors:  K A Voss; J B Gelineau-van Waes; R T Riley
Journal:  Mycotoxin Res       Date:  2006-03       Impact factor: 3.833

Review 3.  An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme.

Authors:  K A Voss; R T Riley; W P Norred; C W Bacon; F I Meredith; P C Howard; R D Plattner; T F Collins; D K Hansen; J K Porter
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

4.  Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border.

Authors:  Stacey A Missmer; Lucina Suarez; Marilyn Felkner; Elaine Wang; Alfred H Merrill; Kenneth J Rothman; Katherine A Hendricks
Journal:  Environ Health Perspect       Date:  2006-02       Impact factor: 9.031

5.  Inhibition of fumonisin B1 cytotoxicity by nanosilicate platelets during mouse embryo development.

Authors:  Yu-Jing Liao; Jenn-Rong Yang; Shuen-Ei Chen; Sing-Jhou Wu; San-Yuan Huang; Jiang-Jen Lin; Lih-Ren Chen; Pin-Chi Tang
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 6.  Developmental Toxicity of Mycotoxin Fumonisin B₁ in Animal Embryogenesis: An Overview.

Authors:  Chompunut Lumsangkul; Hsin-I Chiang; Neng-Wen Lo; Yang-Kwang Fan; Jyh-Cherng Ju
Journal:  Toxins (Basel)       Date:  2019-02-13       Impact factor: 4.546

7.  Trabecular Bone Parameters, TIMP-2, MMP-8, MMP-13, VEGF Expression and Immunolocalization in Bone and Cartilage in Newborn Offspring Prenatally Exposed to Fumonisins.

Authors:  Ewa Tomaszewska; Halyna Rudyk; Izabela Świetlicka; Monika Hułas-Stasiak; Janine Donaldson; Marta Arczewska; Siemowit Muszyński; Piotr Dobrowolski; Maria Mielnik-Błaszczak; Marcin Bartłomiej Arciszewski; Volodymyr Kushnir; Oksana Brezvyn; Viktor Muzyka; Ihor Kotsyumbas
Journal:  Int J Mol Sci       Date:  2021-11-20       Impact factor: 5.923

8.  The Influence of Prenatal Fumonisin Exposure on Bone Properties, as well as OPG and RANKL Expression and Immunolocalization, in Newborn Offspring Is Sex and Dose Dependent.

Authors:  Ewa Tomaszewska; Halyna Rudyk; Izabela Świetlicka; Monika Hułas-Stasiak; Janine Donaldson; Marta Arczewska; Siemowit Muszyński; Piotr Dobrowolski; Iwona Puzio; Volodymyr Kushnir; Oksana Brezvyn; Viktor Muzyka; Ihor Kotsyumbas
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.